No.4
公告
2026/11/10 08:41
事業の狀況
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL APPLICATION SUBMISSION OF NOVEL DUAL TARGETING SIRNA SR122 FOR TREATMENT OF MIXED DYSLIPIDEMIA AND SEVERE HYPERTRIGLYCERIDEMIA
VOLUNTARY ANNOUNCEMENT - PHASE I CLINICAL TRIAL APPLICATION SUBMISSION OF NOVEL DUAL TARGETING SIRNA SR122 FOR TREATMENT OF MIXED DYSLIPIDEMIA AND SEVERE HYPERTRIGLYCERIDEMIA